1. 1672PMaintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study. (23rd October 2018) Authors: Thomas, M; Ponce Aix, S; Navarro Mendivil, A; Riera Knorrenschild, J; Schmidt, M; Wiegert, E; Kapp, K; Mauri, C; Domine Gomez, M; Kollmeier, J; Sadjadian, P; Fröhling, K-P; Huber, R M; Wolf, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S12.2 Type I interferons and their autoantibodies in the context of systemic lupus erythematosus. (27th September 2022) Authors: Haljasmägi, L; Bradford, H; Menon, M; Peterson, P; Vanker, M; Wincup, C; Bondet, V; Duffy, D; Isenberg, D; Kisand, K; Mauri, C Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗